Provence Wealth Management Group Purchases 614 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Provence Wealth Management Group lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 33.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,468 shares of the healthcare conglomerate’s stock after purchasing an additional 614 shares during the quarter. Provence Wealth Management Group’s holdings in UnitedHealth Group were worth $1,299,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Verdence Capital Advisors LLC lifted its position in shares of UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after acquiring an additional 342 shares during the period. Ascension Capital Advisors Inc. acquired a new stake in UnitedHealth Group during the third quarter worth about $216,000. Bellecapital International Ltd. lifted its holdings in shares of UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after acquiring an additional 193 shares during the period. Great Valley Advisor Group Inc. raised its position in UnitedHealth Group by 5.8% during the third quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after purchasing an additional 1,884 shares in the last quarter. Finally, Rise Advisors LLC increased its stake in shares of UnitedHealth Group by 326.0% in the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock valued at $112,000 after purchasing an additional 163 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH stock traded down $0.52 during mid-day trading on Friday, hitting $492.45. The company’s stock had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The company’s fifty day simple moving average is $482.32 and its 200-day simple moving average is $512.76. The company has a market cap of $453.09 billion, a PE ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.26 EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Truist Financial reiterated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Stephens reaffirmed an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. Finally, Piper Sandler boosted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.